Nanogen, Inc. and SynX Pharma Inc. announced today that the Ontario Superior Court of Justice has approved the plan of arrangement for Nanogen to acquire SynX in an all-stock transaction.
SynX shareholders and debenture holders met in Toronto on April 15, where they overwhelmingly approved the transaction by 99.8% and 100% of the votes respectively.
The total consideration for the SynX common shares is fixed at approximately CDN$16.3 million. With approximately 11.4 million SynX shares and share equivalents outstanding, it is expected that each SynX common shareholder will be entitled to receive approximately CDN$1.426 per SynX share in Nanogen common stock. The exchange ratio will be determined on the closing date. At closing, Nanogen will acquire the existing CDN$3.5 million principal amount of subordinated secured debentures of SynX in exchange for shares of Nanogen common stock.
The closing of the transaction, which is currently scheduled for April 21, 2004, is subject to other regulatory approvals and other customary closing conditions.
Posted 19th April 2004
Please use one of the following formats to cite this article in your essay, paper or report:
Nanogen. (2013, June 11). Nanogen Receives Court Approval to Acquire SynX Pharma - News Item. AZoNano. Retrieved on June 01, 2023 from https://www.azonano.com/article.aspx?ArticleID=785.
Nanogen. "Nanogen Receives Court Approval to Acquire SynX Pharma - News Item". AZoNano. 01 June 2023. <https://www.azonano.com/article.aspx?ArticleID=785>.
Nanogen. "Nanogen Receives Court Approval to Acquire SynX Pharma - News Item". AZoNano. https://www.azonano.com/article.aspx?ArticleID=785. (accessed June 01, 2023).
Nanogen. 2013. Nanogen Receives Court Approval to Acquire SynX Pharma - News Item. AZoNano, viewed 01 June 2023, https://www.azonano.com/article.aspx?ArticleID=785.
Do you have a review, update or anything you would like to add to this article?
Cancel reply to comment
Dr. Jeffrey Dick
In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Dr. Jeffrey Dick about his work studying the chemistry of small volumes and nano-electrochemical tools.
Here, AZoNano speaks with Dirigent Acoustics about the benefits graphene could bring to acoustic and audio technologies and how the company's relationship with the Graphene Flagship has shaped its success.
In this interview, KLA's Bryan Crawford explains everything there is to know about nanoindentation, the challenges that the field currently faces, and how they can be overcome.
The Diamond Interaction Chamber (DIXC) is integral to the NanoGenizer high-pressure homogenizer.
The new AUTOsample-100 mounting autosampler is compatible with the 100 MHz benchtop NMR spectrometer.
The Vistec SB3050-2 is the most advanced electron beam lithography system with variable-shaped beam technology, allowing a wide range of applications in research and development, prototyping, and small-volume production.